Floatz logo

cc-90005

Parapsoriasis

CelgenePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Parapsoriasis cohort.

Asset / SponsorPhaseRating
Bexarotene
Fox Chase Cancer Center
Phase 2CCC

Same molecule, other indications

cc-90005 is also rated in:

Healthy VolunteersDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →